Tudor Investment Corp
CALA

Tudor Investment Corp’s Calithera Biosciences, Inc CALA Stock Holding History

Tudor Investment Corp’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,348
Closed -$27K – 2656
2022
Q1 		$27K Hold
3,348
– – ﹤0.01% 1892
2021
Q4 		$45K Buy
3,348
+2,001
+149% +$50.3K ﹤0.01% 2274
2021
Q3 		$59K Buy
+1,347
New +$58.1K ﹤0.01% 2378
2021
Q2 		– Sell
-3,988
Closed -$193K – 2114
2021
Q1 		$193K Buy
3,988
+3,019
+312% +$176K ﹤0.01% 1441
2020
Q4 		$95K Buy
+969
New +$84.9K ﹤0.01% 1271
2019
Q3 		– Sell
-4,970
Closed -$388K – 1423
2019
Q2 		$388K Buy
+4,970
New +$564K 0.01% 792
2018
Q3 		– Sell
-604
Closed -$60K – 1326
2018
Q2 		$60K Sell
604
-1,014
-63% -$115K ﹤0.01% 1000
2018
Q1 		$204K Sell
1,618
-147
-8% -$22.9K 0.01% 863
2017
Q4 		$295K Buy
+1,765
New +$452K 0.01% 807
2017
Q2 		– Sell
-4,986
Closed -$1.15M – 1468
2017
Q1 		$1.15M Buy
+4,986
New +$861K 0.04% 328

Other funds holding CALA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCMG
TSP Capital Management Group Summit, New Jersey $410M AUM 71.81% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Tudor Investment Corp's CALA Position: Q2 2022 in Review

Tudor Investment Corp sold out of Calithera Biosciences, Inc (CALA) in Q2 2022, closing a stake of 3,348 shares — an estimated $27K sold.

Tudor Investment Corp first reported a position in CALA in Q1 2017 and held it in 10 quarters. The position peaked at $1.15M in Q1 2017. 28 funds tracked by Wall St. Rank hold CALA as of Q2 2022.

  • Tudor Investment Corp reported no remaining Calithera Biosciences, Inc position as of Q2 2022 after selling out during the quarter.
  • Tudor Investment Corp sold 3,348 Calithera Biosciences, Inc shares in Q2 2022, an estimated $27K.
  • Tudor Investment Corp first reported a position in Calithera Biosciences, Inc in Q1 2017 and held it in 10 quarters.
  • Tudor Investment Corp's Calithera Biosciences, Inc position peaked at $1.15M in Q1 2017.
  • 28 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q2 2022.

Based on Tudor Investment Corp's 13F filing for Q2 2022, filed 15 Aug 2022.